AXGN Axogen, Inc.
AXGN Axogen, Inc.
Healthcare · Medical Devices
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $43.22 · VWAP $37.41 · +1.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster EVP, Director + 1 other sold $4.5M, Aug 11–12
Coverage
1 watchlist
AXGN Price Structure
Loading timeframes…
Peers
Every watchlist AXGN belongs to, members best 30-day change first — AXGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: revenue $70M, diluted EPS -$0.03, net income -$2M (SEC filing). Across the print the stock moved +0.5% (close before → first close after).
full note →Against street estimates
How AXGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about AXGN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 6 days ago · Oct 17
- Press Releases :: Axogen, Inc. (AXGN)
- Axogen (AXGN) Stock Price History 2011-2026
- Axogen, Inc. (AXGN)
- Axogen, Inc. 8-K exhibit 99.1: EX-99.1 PRESS RELEASE, filed October 1, 2026
- Axogen, Inc. 8-K filed September 10, 2026
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
AXGN research tape
73 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.